DOSSIER · 13F Holders · Q3 2026Healthcare · Drug Manufacturers - General
LLY

ELI LILLY & CO

4,921 institutions still hold ELI LILLY & CO as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.

CUSIP 532457108·Drug Manufacturers - General·4,921 13F holders·last filed Sep 30, 2026
Market cap
$850.0B
13F value held
$612.4B
visible holders
Holders
4,921
filers reporting
Concentration
17.02%
LILLY ENDOWMENT INC #1
top holder share
AI Holders Summary · Q3 2026

LLY registers 4,219 institutional filers with roughly $647 billion in combined 13F value, but the register has a distinctive owner at its apex: Lilly Endowment Inc, founded by Eli Lilly himself, sits at the top with roughly $84 billion—a uniquely concentrated founder-linked position that is almost unheard of in the S&P 500. Beneath it, healthcare-oriented active managers like Capital Research Global Investors and FMR maintain deliberate allocations, while passive vehicles continue their standard broad-market loading.

The passive core follows standard patterns. BlackRock ($61.2 billion), Vanguard Capital Management ($49.1 billion), State Street ($32.8 billion), FMR/Fidelity ($24.2 billion), and Geode ($18.5 billion) form the typical passive-majority top tier. Vanguard Portfolio Management added LLY as a new position this quarter, indicating that an ETF or sleeve rebalance pulled the name into a vehicle that previously did not hold it.

The more informative register read is in the active-manager tier. Capital Research Global Investors extended its position slightly—shares up modestly, signaling an active upgrade. FMR/Fidelity added roughly $613 million in notional value. JPMorgan grew its stake by about $1.8 billion, and Wellington Management added roughly $2.0 billion. These four names are healthcare-oriented or balanced-growth allocators with fundamental research infrastructure dedicated to pharmaceutical and biotech sector analysis; their collective behavior carries more weight than a generic large-cap active manager's LLY position.

Analysis generated by 13F Insight from SEC Form 13F filing data · Q3 2026. Methodology

Top holders

Sorted by position value. Source: SEC EDGAR 13F-HR filings.

#HolderValueShares% port.Quarter
01
LILLY ENDOWMENT INC
CIK 0000316011
$104.2B90.1M100.00%Q3 2026
02
BlackRock, Inc.
CIK 0002012383
$81.0B67.5M1.20%Q2 2026
03
VANGUARD CAPITAL MANAGEMENT LLC
CIK 0002100119· Index
$64.2B53.5M1.37%Q2 2026
04
PNC FINANCIAL SERVICES GROUP, INC.
CIK 0000713676
$59.1B51.1M34.11%Q3 2026
05
STATE STREET CORP
CIK 0000093751
$43.4B36.2M1.28%Q2 2026
06
FMR LLC
CIK 0000315066
$34.7B30.0M1.50%Q3 2026
07
Capital Research Global Investors
CIK 0001422848
$25.0B20.9M3.49%Q2 2026
08
Vanguard Portfolio Management
CIK 0002100121· Index
$25.0B20.9M1.13%Q2 2026
09
GEODE CAPITAL MANAGEMENT, LLC
CIK 0001214717· Index
$23.7B20.6M1.23%Q3 2026
10
MORGAN STANLEY
CIK 0000895421
$19.5B16.2M1.03%Q2 2026
11
Capital World Investors
CIK 0001422849
$19.1B15.9M2.25%Q2 2026
12
JPMORGAN CHASE & CO
CIK 0000019617
$15.5B12.6M0.86%Q2 2026
13
NORGES BANK
CIK 0001374170· Sovereign
$13.8B11.5M1.37%Q2 2026
14
BANK OF AMERICA CORP /DE/
CIK 0000070858
$13.5B11.3M0.87%Q2 2026
15
WELLINGTON MANAGEMENT GROUP LLP
CIK 0000902219
$13.2B11.0M2.27%Q2 2026
16
STATE FARM MUTUAL AUTOMOBILE INSURANCE CO
CIK 0000315032
$12.9B10.8M8.83%Q2 2026
17
PRICE T ROWE ASSOCIATES INC /MD/
CIK 0000080255
$12.9B14.0M1.49%Q1 2026
18
PRIMECAP MANAGEMENT CO/CA/
CIK 0000763212
$11.0B9.2M6.51%Q2 2026
19
NORTHERN TRUST CORP
CIK 0000073124· Index
$10.6B8.8M1.23%Q2 2026
20
GOLDMAN SACHS GROUP INC
CIK 0000886982
$10.1B8.4M0.88%Q2 2026
Page 1 of 247
4901 more holders available. Log in →
Insiders at ELI LILLY & CO
Jonsson Patrik →Ricks David A →Hakim Anat →Skovronsky Daniel →Brown Adrienne S →Custer Kenneth L. →Dozier Eric →Hernandez Edgardo →